Iovance
IOVA
Iovance (IOVA) news
Recent news
Iovance Biotherapeutics Inc: UBS raises target price to $7 from $4
AInvest Wire · Aug 20, 2026Iovance Biotherapeutics shares rise 38.5% after Q2 revenue beat
Iovance Biotherapeutics (NASDAQ:IOVA) shares rose 38.5% in pre-market trading following the release of second-quarter financial results that exceeded revenue expectations. The company reported stronger-than-anticipated revenue, which, combined with upward revision to financial guidance , has…
AInvest Wire · Aug 6, 2026Iovance Biotherapeutics 2Q loss/share 11c vs. loss/share 33c y/y
AInvest Wire · Aug 6, 2026Iovance Biotherapeutics - reviewing FY2026 revenue guidance of $350 mln to $370 mln
AInvest Wire · Aug 6, 2026Iovance Biotherapeutics shares rise 13.4% premarket after Q2 revenue beat
AInvest Wire · Aug 6, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.